Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)
CapEx to Revenue
0.50%
Quarterly · Period ending:
CANF CapEx to Revenue
Latest reported0.50%period ending
Latest reported0.50%period ending
CANF Quarterly CapEx/Revenue (0.00% → 0.50%)
Latest values, visible window
High-resolution chart · PNG
CANF capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.495% | |
| 0.495% | |
| 0.4926% | |
| 0.4926% | |
| 0.495% | |
| 0.495% | |
| 0.2793% | |
| 0.2793% | |
| 1.2658% | |
| 1.2658% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 1.1255% | |
| 8.9691% | |
| 3.132% | |
| 4.0359% | |
| 5.6388% | |
| 0% |